These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7133239)

  • 21. Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: a multicenter, randomized, two-arm, open-label trial.
    Veerasarn V; Khorprasert C; Lorvidhaya V; Sangruchi S; Tantivatana T; Narkwong L; Kongthanarat Y; Chitapanarux I; Tesavibul C; Panichevaluk A; Puribhat S; Sangkittipaiboon S; Sookpreedee L; Lertsanguansinchai P; Phromratanapongse P; Rungpoka P; Trithratipvikul S; Lojanapiwat B; Ruangdilokrat S; Ngampanprasert P
    Radiother Oncol; 2004 Nov; 73(2):179-85. PubMed ID: 15542165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.
    Fabian CJ; Kimler BF; McKittrick R; Park CH; Lin F; Krishnan L; Jewell WR; Osborne CK; Martino S; Hutchins LF
    Cancer Res; 1994 Oct; 54(20):5357-62. PubMed ID: 7923165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors in uterine cervical and corpus cancer].
    Yoshioka T; Inoue Y; Hoshiai H; Noda K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influense of endogenous and exogenous factors on the development and prognosis of the cancer of the uterine cervix].
    Gatenadze TsZ; Sofrani MF; Dzhincharadze MI; Shotadze DT; Chakhoian OP
    Georgian Med News; 2009 Apr; (169):10-5. PubMed ID: 19430033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood groups of the ABO system and survival rate in gynecologic tumors].
    Marinaccio M; Traversa A; Carioggia E; Valentino L; Coviello M; Salamanna S; Dragone DC; Marinaccio L
    Minerva Ginecol; 1995 Mar; 47(3):69-76. PubMed ID: 7630512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognosis of cervical cancer associated with pregnancy: a matched cohort study.
    van der Vange N; Weverling GJ; Ketting BW; Ankum WM; Samlal R; Lammes FB
    Obstet Gynecol; 1995 Jun; 85(6):1022-6. PubMed ID: 7770248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma.
    Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Shumin Z; Lili D
    Biol Trace Elem Res; 2003 Aug; 94(2):113-22. PubMed ID: 12958402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association between endogenous hormones, hormone receptors and cervical cancer].
    Wang JT; Gao ES; Ding L; Cheng YY; Yan JW
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):494-7. PubMed ID: 17147111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
    Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late effects of radiation therapy for cancer of the uterine cervix.
    Zippin C; Lum D; Kohn HI; Bailar JC
    Cancer Detect Prev; 1981; 4(1-4):487-92. PubMed ID: 7349815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum copper levels in carcinoma of ovary and cervix.
    Saxena P; Yadav S; Salhan S; Bhowmick KT
    Indian J Physiol Pharmacol; 2002 Apr; 46(2):159-66. PubMed ID: 12500490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy of cancer of the uterine cervix and successive appearance of new malignant growth in the irradiated field].
    Russo F; Spina C; Coscarella G; Sileri PP; Arturi A; Stolfi VM
    Minerva Ginecol; 1997; 49(7-8):345-54. PubMed ID: 9380297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis in cervical cancer cells: implications for adjunct anti-estrogen therapy for cervical cancer.
    Chen D; Carter TH; Auborn KJ
    Anticancer Res; 2004; 24(5A):2649-56. PubMed ID: 15517869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of tumor cells in the peripheral blood of patients with cancer of the uterine cervix].
    Kosareva AN; Iakovleva MP
    Vopr Onkol; 1972; 18(2):86-7. PubMed ID: 5012923
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution of ABO blood groups in women with multiple primary neoplasms - cancer of the breast and cervix uteri].
    Pawełczyk Z
    Wiad Lek; 1983 Sep; 36(18):1515-8. PubMed ID: 6666131
    [No Abstract]   [Full Text] [Related]  

  • 39. [Histological prognosis in cancer of the uterine cervix].
    Vasilev B; Makaveeva V
    Akush Ginekol (Sofiia); 1968; 7(2):174-82. PubMed ID: 5681833
    [No Abstract]   [Full Text] [Related]  

  • 40. [Protein composition of the blood in cancer of the uterine cervix].
    Burlak ZF; Ul'ianova LS
    Pediatr Akus Ginekol; 1965; 5():60-1. PubMed ID: 5872195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.